DUKPC 2022: The Use of AI, Machine Learning and Digital Therapeutics for Behavioral Modification

At the 2022 Diabetes UK Professional Conference (DUKPC), Glooko Chief Medical Officer Mark Clements, M.D., Ph.D. shared how AI, machine learning and digital therapeutics can help provide a customized care and more tailored therapy regimen for people with diabetes and related chronic conditions.

Watch the presentation to learn how Just-In-Time Adaptive Interventions (JITAI) nudge individuals toward health-promoting behaviors, as well as how DTx combined with AI and machine learning can enable more effective clinical observations and management for different cohorts.